Potential Benefits of an Innovative New Device in Septic Shock

DURHAM, N.C., Oct. 31, 2018 /PRNewswire/ -- 410 Medical, Inc., a medical device company focused on the development of innovative technologies for the treatment of critically ill patients, today announced a recent publication in Open Access Emergency Medicine. The study, published on October 26, 2018 used an analytic model to evaluate the potential impact of LifeFlow, a new device for rapid, controlled delivery of fluids, in patients with severe sepsis and septic shock. The results of the study demonstrated decreased mortality, less need for vasopressors or mechanical ventilation, and a hospital cost savings of approximately $1.5MM per year over 500 patients.